Innovate (Innovate) Interest Expense : $-69.80 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Innovate Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Innovate's interest expense for the three months ended in Mar. 2024 was $ -17.20 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-69.80 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Innovate's Operating Income for the three months ended in Mar. 2024 was $ 2.80 Mil. Innovate's Interest Expense for the three months ended in Mar. 2024 was $ -17.20 Mil. Innovate's Interest Coverage for the quarter that ended in Mar. 2024 was 0.16. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Innovate Interest Expense Historical Data

The historical data trend for Innovate's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovate Interest Expense Chart

Innovate Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-76.10

-74.80

-59.10

-52.00

-68.20

Innovate Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-15.60	-16.30	-17.10	-19.20	-17.20

Innovate Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-69.80 Mil.

Innovate (OTCPK:HCCDZ.PFD) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Innovate's Interest Expense for the three months ended in Mar. 2024 was $-17.20 Mil. Its Operating Income for the three months ended in Mar. 2024 was $2.80 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $688.30 Mil.

Innovate's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	2.8	/	-17.2
	=	0.16

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Innovate Corps earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.

Innovate (Innovate) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Innovate Corp (OTCPK:HCCDZ.PFD) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

VATE:USA PSTA:Germany

Address

295 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

https://www.innovatecorp.com

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.